Octapharma AG - Strategy, SWOT and Corporate Finance Report
Octapharma AG - Strategy, SWOT and Corporate Finance Report
SUMMARY
Octapharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
KEY HIGHLIGHTS
Octapharma AG (Octapharma or 'the company') is a human proteins manufacturer involved in the development and sale of human proteins for use in pharmaceuticals and medical treatments. Its product portfolio comprises of protein and other biopharmaceutical products derived from human plasma in three therapeutic areas: haematology, critical care, and immunotherapy. The company operates manufacturing facilities in Austria, France, Sweden, Germany, and Mexico. In addition, its research and development (R&D) facilities are also involved in research and development of human proteins for various therapeutic areas. The company operates through its subsidiaries in Europe, North and South Americas, Asia Pacific and the Middle East. Octapharma is headquartered in Lachen, Switzerland.
SCOPE
SUMMARY
Octapharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
KEY HIGHLIGHTS
Octapharma AG (Octapharma or 'the company') is a human proteins manufacturer involved in the development and sale of human proteins for use in pharmaceuticals and medical treatments. Its product portfolio comprises of protein and other biopharmaceutical products derived from human plasma in three therapeutic areas: haematology, critical care, and immunotherapy. The company operates manufacturing facilities in Austria, France, Sweden, Germany, and Mexico. In addition, its research and development (R&D) facilities are also involved in research and development of human proteins for various therapeutic areas. The company operates through its subsidiaries in Europe, North and South Americas, Asia Pacific and the Middle East. Octapharma is headquartered in Lachen, Switzerland.
SCOPE
- Detailed information on Octapharma AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Octapharma AG in the form of a SWOT analysis
- An in-depth view of the business model of Octapharma AG including a breakdown and examination of key business segments
- Intelligence on Octapharma AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Octapharma AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Octapharma AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Octapharma AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Octapharma AG's business structure, strategy and prospects.
Company Snapshot
Table of Contents
Octapharma AG: Company Overview
Octapharma AG: Overview and Key Facts
Octapharma AG: Overview
Octapharma AG: Key Facts
Octapharma AG: Key Employees
Octapharma AG: Major Products and Services
Octapharma AG: Company History
Octapharma AG: Management Statement
Octapharma AG: Locations and Subsidiaries
Octapharma AG: Key Competitors
Octapharma AG: Company Analysis
Octapharma AG: Business Description
Octapharma AG: SWOT Analysis
Octapharma AG: SWOT Overview
Octapharma AG: Strengths
Octapharma AG: Weaknesses
Octapharma AG: Opportunities
Octapharma AG: Threats
Octapharma AG: Corporate Financial Deals Activity
Octapharma AG: Financial Deals Overview
Octapharma AG: Targets and Partners
Octapharma AG: Top Deals 2014 - 2018YTD*
Octapharma AG: Corporate Venturing
Octapharma AG: Partnership
Octapharma AG: Recent Developments
Octapharma AG: News and Events Summary
Octapharma AG: Financial Performance
Octapharma AG: Regulatory and Legal Events
Octapharma AG: Research & Development
Appendix
Contact Us
Methodology
About MarketLine
Table of Contents
Octapharma AG: Company Overview
Octapharma AG: Overview and Key Facts
Octapharma AG: Overview
Octapharma AG: Key Facts
Octapharma AG: Key Employees
Octapharma AG: Major Products and Services
Octapharma AG: Company History
Octapharma AG: Management Statement
Octapharma AG: Locations and Subsidiaries
Octapharma AG: Key Competitors
Octapharma AG: Company Analysis
Octapharma AG: Business Description
Octapharma AG: SWOT Analysis
Octapharma AG: SWOT Overview
Octapharma AG: Strengths
Octapharma AG: Weaknesses
Octapharma AG: Opportunities
Octapharma AG: Threats
Octapharma AG: Corporate Financial Deals Activity
Octapharma AG: Financial Deals Overview
Octapharma AG: Targets and Partners
Octapharma AG: Top Deals 2014 - 2018YTD*
Octapharma AG: Corporate Venturing
Octapharma AG: Partnership
Octapharma AG: Recent Developments
Octapharma AG: News and Events Summary
Octapharma AG: Financial Performance
Octapharma AG: Regulatory and Legal Events
Octapharma AG: Research & Development
Appendix
Contact Us
Methodology
About MarketLine
LIST OF TABLES
Table 1: Octapharma AG: Key Facts
Table 2: Octapharma AG: Key Employees
Table 3: Octapharma AG: Locations and Subsidiaries
Table 4: Octapharma AG: Key Competitors
Table 5: Octapharma AG: Deal Activity by Deal Type - Volume (2014 - YTD2018)
Table 6: Octapharma AG: Targets and Partners
Table 7: Octapharma AG: Top Deals 2014 - 2018YTD
Table 8: Octapharma AG: Corporate Venturing Volume and Value Trend (2014 - YTD2018)
Table 9: Octapharma AG: Corporate Venturing by Geography (2014 - YTD2018)
Table 10: Octapharma AG: Partnership Volume and Value Trend (2014 - YTD2018)
Table 11: Octapharma AG: Partnership Trend by Deal Type (2014 - YTD2018)
Table 12: Octapharma AG: News and Events Summary
Table 13: Octapharma AG: Financial Performance
Table 14: Octapharma AG: Regulatory and Legal Events
Table 15: Octapharma AG: Research & Development
Table 1: Octapharma AG: Key Facts
Table 2: Octapharma AG: Key Employees
Table 3: Octapharma AG: Locations and Subsidiaries
Table 4: Octapharma AG: Key Competitors
Table 5: Octapharma AG: Deal Activity by Deal Type - Volume (2014 - YTD2018)
Table 6: Octapharma AG: Targets and Partners
Table 7: Octapharma AG: Top Deals 2014 - 2018YTD
Table 8: Octapharma AG: Corporate Venturing Volume and Value Trend (2014 - YTD2018)
Table 9: Octapharma AG: Corporate Venturing by Geography (2014 - YTD2018)
Table 10: Octapharma AG: Partnership Volume and Value Trend (2014 - YTD2018)
Table 11: Octapharma AG: Partnership Trend by Deal Type (2014 - YTD2018)
Table 12: Octapharma AG: News and Events Summary
Table 13: Octapharma AG: Financial Performance
Table 14: Octapharma AG: Regulatory and Legal Events
Table 15: Octapharma AG: Research & Development
LIST OF FIGURES
Figure 1: Octapharma AG: Deal Activity by Deal Type - Volume (2014 - YTD2018)
Figure 2: Octapharma AG: Corporate Venturing Volume and Value Trend (2014 - YTD2018)
Figure 3: Octapharma AG: Corporate Venturing by Geography (2014 - YTD2018)
Figure 4: Octapharma AG: Partnership Volume and Value Trend (2014 - YTD2018)
Figure 5: Octapharma AG: Partnership Trend by Deal Type (2014 - YTD2018)
Figure 1: Octapharma AG: Deal Activity by Deal Type - Volume (2014 - YTD2018)
Figure 2: Octapharma AG: Corporate Venturing Volume and Value Trend (2014 - YTD2018)
Figure 3: Octapharma AG: Corporate Venturing by Geography (2014 - YTD2018)
Figure 4: Octapharma AG: Partnership Volume and Value Trend (2014 - YTD2018)
Figure 5: Octapharma AG: Partnership Trend by Deal Type (2014 - YTD2018)
